Evaluating the Impact of Pharmacist-Driven Protocols on Anticoagulation Therapy in Hospitalized Patients: Prevention of Bleeding Complications and Thromboembolic Events

Authors: Sahar A. Alsuliami Alharbi

DOI: https://doi.org/10.5281/zenodo.13736291

Short DOI: https://doi.org/gvh7bw

Country: Saudi Arabia

Full-text Research PDF File:   View   |   Download

Abstract: This study evaluates the outcomes of pharmacist-driven protocols for managing anticoagulation therapy in hospitalized patients at a large tertiary hospital. A retrospective analysis of 500 patients revealed that those managed under pharmacist-led protocols experienced a significantly lower incidence of major bleeding complications (6.0% vs. 11.2%) and had a higher mean time in therapeutic range (TTR) for warfarin therapy (68.5% vs. 55.3%) compared to those receiving standard care. Although the reduction in thromboembolic events was not statistically significant, the findings underscore the critical role of pharmacists in optimizing anticoagulation therapy and enhancing patient safety.

Keywords: Anticoagulation therapy, pharmacist-driven protocols, bleeding complications, thromboembolic events, time in therapeutic range, patient safety, hospital care

Paper Id: 231143

Published On: 2016-02-02

Published In: Volume 4, Issue 1, January-February 2016

Cite This: Evaluating the Impact of Pharmacist-Driven Protocols on Anticoagulation Therapy in Hospitalized Patients: Prevention of Bleeding Complications and Thromboembolic Events - Sahar A. Alsuliami Alharbi - IJIRMPS Volume 4, Issue 1, January-February 2016. DOI 10.5281/zenodo.13736291

Share this